Prolyl oligopeptidase inhibition ameliorates experimental pulmonary fibrosis both in vivo and in vitro

BACKGROUND: Pulmonary fibrosis is a progressive disease characterized by lung remodeling due to excessive deposition of extracellular matrix. Although the etiology remains unknown, aberrant angiogenesis and inflammation play an important role in the development of this pathology. In this context, re...

Descripción completa

Detalles Bibliográficos
Autores principales: Cucinotta, Laura, Mannino, Deborah, Casili, Giovanna, Repici, Alberto, Crupi, Lelio, Paterniti, Irene, Esposito, Emanuela, Campolo, Michela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463606/
https://www.ncbi.nlm.nih.gov/pubmed/37626373
http://dx.doi.org/10.1186/s12931-023-02519-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463606/
https://www.ncbi.nlm.nih.gov/pubmed/37626373
http://dx.doi.org/10.1186/s12931-023-02519-x

Ejemplares similares